Vision-Sciences (VSCI) Cash Flow Statement

Click line-items for a historical chart and %

Net loss	-3.52M
Depreciation and amortization	2.36M
Stock-based compensation expense	440K
Issuance of restricted stock awards
Provision for (recovery of) bad debt expenses
Debt cost expense
Loss on disposal of fixed asset
Accounts receivable	1.4M
Inventories	-1.64M
Prepaid expenses and other current assets
Accounts payable	394.57K
Accrued expenses	213.39K
Accrued compensation
Advances from customers	220.79K
Net cash used in operating activities
Purchase of short-term investments
Proceeds from short-term investment sales/maturities
Purchase of property and equipment	-232.33K
Net cash used in investing activities
Advance on line of credit—related party
Payments of capital leases
Proceeds from exercise of stock options
Common stock repurchased
Net cash provided by financing activities
Net decrease in cash and cash equivalents	2.26M
Cash and cash equivalents at beginning of period	1.98M
Cash and cash equivalents at end of period	4.24M
Interest	47.75K
Income taxes	35.42K
Net transfers of inventory to fixed assets for use as demonstration equipment
Capital lease entered into for equipment purchase
Issuance of stock warrants with line of credit—related party

Entities mentioned with VSCI

View All Entities